| PDSB Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the PDSB shares outstanding history going back to 3/18/2019:
Also see: PDSB Market Cap History PDSB YTD Return |
PDSB Shares Outstanding History — PDS Biotechnology Share Count Over Time
As of 8/6/2026 PDS Biotechnology has 55.97 million PDSB shares outstanding. Investors often track the PDSB shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows PDSB share count trends over time, with 31 historical shares outstanding datapoints presented, dating back to 3/18/2019.
| PDSB Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PDSB Historical Shares Outstanding: +37.39% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PDSB Stock Price Chart |
| About PDS Biotechnology Corp |
| PDS Biotechnology Corporation is a clinical-stage immunotherapy company. Co. is developing a pipeline of targeted cancer immunotherapies based on its Versamune T cell-activator and Versamune in combination with its interleukin 12 (IL-12) fused antibody drug conjugate (ADC), PDS01ADC, a tumor targeting immunocytokine. PDS0101 is its lead Versamune based immunotherapy. PDS0101 combines Versamune with a mixture of short proteins (peptides) derived from the cancer-causing HPV16 viral protein. Versamune is a proprietary lipid nanoparticle and T cell activating platform. We show 31 historical shares outstanding datapoints in our coverage of PDSB's shares outstanding history. Understanding the changing numbers of PDSB shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PDSB versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PDSB by allowing them to research PDSB shares outstanding history as well as any other stock in our coverage universe. |
| PDSB Current Stock Quote |
Quotes delayed 20 minutes  Free PDSB Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| PDSB Share Performance |
| Shares Outstanding Peers |
| PDS Biotechnology (PDSB) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
PEN Shares Outstanding History PEPG Shares Outstanding History PETV Shares Outstanding History PETX Shares Outstanding History PFE Shares Outstanding History PGEN Shares Outstanding History PGNX Shares Outstanding History PGNY Shares Outstanding History PHAS Shares Outstanding History PHAT Shares Outstanding History More Healthcare companies » |
PDSB Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
